Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Riley Mccormack Insider Profile
4 Followers
Riley Mccormack, Ten Percent Owner at Oruka Therapeutics, holds 3.79M shares in Digimarc (Ticker: DMRC), holds 2.10M shares in Oruka Therapeutics (Ticker: ORKA).
Riley Mccormack Oruka Therapeutics (ORKA)Ten Percent Owner
Oruka Therapeutics (ORKA)
Ten Percent Owner
Ranked #61,202 out of 98,834 Corporate Insiders
Profitable Transactions
2 out of 5 Profitable Transactions
Average Return
-6.90%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Riley Mccormack holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Sell
Date:Jan 16, 2015 - Jan 16, 2016
Return:+34.00%
The most profitable trade made by Riley Mccormack
Riley Mccormack's Trading History
Oruka Therapeutics
Jan 16, 2015
Ten Percent Owner
Informative Sell
267.50K
$53.30M
Digimarc
Feb 17, 2023
CEO, Director, Ten Percent Owner
Uninformative Buy
29.28K
$105.69M
List of latest transactions for each holding click on a transaction to see Riley Mccormack's performance on stock
You May Also Like
Riley Mccormack insider profile FAQ
What is the percentage of profitable transactions made by Riley Mccormack?
The percentage of profitable transactions made by Riley Mccormack is 40%.
What is the average return per transaction made by Riley Mccormack?
The average return per transaction made by Riley Mccormack is -6.90%.
What stocks does Riley Mccormack hold?
Riley Mccormack holds: ORKA, DMRC stocks.
What was Riley Mccormack’s latest transaction?
Riley Mccormack latest transaction was an Uninformative Buy of $29.28K.
What was Riley Mccormack's most profitable transaction?
Riley Mccormack’s most profitable transaction was an Informative Sell of ORKA stock on January 16, 2015. The return on the trade was 34.00%.
What is Riley Mccormack's role in Oruka Therapeutics?
Riley Mccormack's role in Oruka Therapeutics is Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.